Molecular subtypes, prognostic factors, and treatment optimization in pediatric medulloblastoma: a real-world study from China
BackgroundMedulloblastoma (MB) is the most common malignant pediatric brain tumor, yet systematic studies on molecular characteristics and treatment efficacy in Chinese pediatric MB remain scarce. This study evaluates recurrence and mortality risk factors and the feasibility of intensified chemother...
Saved in:
| Main Authors: | Jingjing Liu, Yanling Sun, Huming Li, Shuxu Du, Jin Zhang, Zhen Zhang, Liming Sun, Wanshui Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1597123/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor-associated macrophages correlate with better outcome in SHH medulloblastoma
by: Jin Zhang, et al.
Published: (2025-04-01) -
Multifocal medulloblastoma in an adult: a case report and review of the literature
by: Cha Luo, et al.
Published: (2025-05-01) -
Multicentre evaluation of the management of children with high risk medulloblastoma: Real world performance of the SJMB03 and COG-99701 protocols
by: John R. Apps, et al.
Published: (2025-12-01) -
Medulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Reference Network
by: S. Bailey, et al.
Published: (2025-06-01) -
Unveiling the potential benefits of statins in medulloblastoma treatment: A promising therapeutic approach
by: Amir Modarresi Chahardehi, et al.
Published: (2025-12-01)